Navigation Menu Toggle navigation Sign in ...

Researchers have found in a new study that in patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or ...

Real-world data suggest that high-dose formulation ferric carboxymaltose injection (Injectafer; Daiichi Sankyo, Inc) may be a more cost-effective option for patients requiring IV iron therapy ...

About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in ...

Intravenous (IV) iron supplementation with ferric carboxymaltose was found to be well tolerated and improve quality of life in patients with heart failure with reduced ejection fraction (HFrEF) and ...

A new study published in the Turkish Journal of Hematology showed that ferric carboxymaltose may raise hemoglobin and ferritin levels in patients with underlying iron deficiency anemia (IDA) when ...

a ferric carboxymaltose injection to treat iron deficiency. It also provides Liziana and Savaysa, direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT ...

About The Study: In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the ...

ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia. Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below ...